In 2025, Kenya’s healthcare landscape witnessed significant transformation in diagnostics, thanks to visionary leadership from one Mwende Musunga, who blended scientific expertise with strategic management.
As Group CEO of Cerba Lancet Kenya, she has overseen a major expansion and modernisation of the diagnostic provider, ensuring high-quality and accessible healthcare services reach more Kenyans than ever before.
In 2025, Musunga spearheaded initiatives that significantly improved patient access to diagnostic testing. This included expanding laboratory services into underserved counties, reducing turnaround times, and integrating digital systems for faster results.
Under her leadership, Cerba Lancet Kenya also introduced new specialised diagnostic services, including advanced testing for infectious diseases and chronic conditions, positioning the company as a regional leader in precision diagnostics.
Musunga has been recognized for her strategic vision in health management, earning accolades in 2025 for her contribution to elevating standards in private healthcare while maintaining a strong focus on affordability and accessibility.
She has played a pivotal role in professional development within the sector, mentoring laboratory scientists and managers, and promoting capacity-building programs that equip staff with modern diagnostic skills.
Beyond corporate achievements, Musunga is an advocate for integrating private diagnostics into national healthcare priorities. Her efforts in public-private collaboration have enhanced early disease detection and preventive care programs, benefiting thousands of patients nationwide.